Washington, DC, Sept. 26, 2017 -- This September 26 once again marks Mesothelioma Awareness Day. Mesothelioma is a cancer most people have seen in late-night commercials, but few know much about.
|
|||
The Mesothelioma Applied Research Foundation (Meso Foundation) is taking this opportunity to increase awareness of this cancer and educate the general public about its one main risk factor: asbestos.
Mesothelioma is a cancer usually associated with asbestos exposure. It is most often found in the lining of the lung or abdomen, and sometimes other organs as well.
The Meso Foundation states that it is a common misconception that asbestos has been banned or that regulations are in place to protect the public. In fact, they state, asbestos has still not been banned in the United States and while it is no longer manufactured here, it is still imported in a number of products. Although asbestos is regulated through workplace laws which help prevent occupational exposure, they do not protect the general public, as homes built between the 1940s and 1980s are likely to contain asbestos already (attic insulation, plaster, tiling, pipe insulation, etc…).
According to the organization, Do-It-Yourself-ers and “weekend renovators” are especially at risk when renovating or repairing homes and if doing the work in an occupied residence, all residents living in the home are at risk of inhaling microscopic asbestos fibers which are easily distributed throughout the home through HVAC system.
Mesothelioma can take between 20-50 years to develop from the time of inhalation of asbestos. The cancer is known as very aggressive and survival at five years from diagnosis is less than 10%.
However, for some patients appropriate treatment can greatly extend survival. Although the FDA approved only one treatment regimen for mesothelioma in 2004 (chemotherapy combination of Alimta/cisplatin), mesothelioma patients should be aware of all of their options many of which include surgery and experimental drugs (through clinical trials).
The Mesothelioma Applied Research Foundation can be a resource to those who have been diagnosed by helping them and their families navigate available treatment options, access treatment and clinical trials, and provide financial assistance. Mesothelioma patients who need help can contact Gleneara Bates, MSW, the organization’s Director of Research and Medical Outreach at (703) 879-3821 or [email protected].
Additional information can be found at www.curemeso.org.
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/804ba210-e3e2-448d-8b1e-c400b1a4c3a4
Maja Belamaric Mesothelioma Applied Research Foundation 7038793822 [email protected]


FedEx Pilots and Union Reach Tentative Agreement on 40% Pay Increase
Pershing Square Bids €30.40 Per Share to Acquire Universal Music Group in $9.4B Deal
Kia Cuts EV Sales Target for 2030 Amid Slowing Demand and U.S. Policy Shifts
Anthropic's Mythos AI Model Sparks Emergency Cybersecurity Meeting With Top U.S. Bank CEOs
Apple's Foldable iPhone Faces Engineering Setbacks, Mass Production Timeline at Risk
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
Tokyo Electric Power Attracts Major Investors Amid Billion-Dollar Restructuring Push
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG
TSMC Posts Strong Q1 2025 Revenue, Riding AI Chip Demand Wave
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts
China's AI Stocks Surge as Zhipu and MiniMax Hit Record Highs
Anthropic Fights Pentagon Blacklisting in Dual Federal Court Battles
Ford Issues Major Recall on Over 422,000 Vehicles Due to Windshield Wiper Defect
Deere & Company Agrees to $99 Million Settlement Over Right-to-Repair Dispute
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth 



